Aztreonam avibactam clinical trials have evaluated the combination in serious Gram-negative bacterial infections, including complicated intra-abdominal infections, hospital-acquired or ventilator-associated pneumonia, and infections caused by metallo-beta-lactamase (MBL)-producing organisms. Clinical studies such as REVISIT, ASSEMBLE and REJUVENATE provide evidence about efficacy, microbiological response and safety, while also showing important limitations in the current evidence base. Aztreonam-avibactam...Read More